Equities researchers at William Blair increased their FY2026 EPS estimates for argenx in a research note issued on Friday, ...
Investment analysts at William Blair boosted their Q3 2026 earnings per share (EPS) estimates for shares of Salesforce in a ...
William Blair issued their Q1 2026 EPS estimates for Cullinan Therapeutics in a report issued on Thursday, February 27th. William Blair analyst M. Phipps expects that the company will post earnings of ...
William Blair issued their Q1 2026 earnings estimates for shares of Verve Therapeutics in a report issued on Thursday, ...
Analysts at William Blair issued their Q1 2026 earnings estimates for shares of Rocket Pharmaceuticals in a note issued to ...
William Blair issued their Q1 2026 earnings per share estimates for shares of Workday in a report released on Wednesday, ...
Analysts at William Blair issued their Q1 2026 earnings estimates for shares of Entrada Therapeutics in a report issued on Thursday, February 27th. William Blair analyst M. Minter expects that the ...
William Blair restated their outperform rating on shares of Alignment Healthcare (NASDAQ:ALHC – Free Report) in a research report released on Friday,RTT News reports. Several other equities research ...
William Blair restated their outperform rating on shares of Colliers International Group (NASDAQ:CIGI – Free Report) (TSE:CIGI) in a report published on Friday morning,RTT News reports. Other equities ...
Equities researchers at William Blair issued their Q2 2025 earnings estimates for shares of Vital Farms in a report issued on Thursday, February 27th. William Blair analyst J. Andersen forecasts that ...
The Spartans left no doubt. Despite Oklahoma commit Alec Blair going down early in the second half with a sprained right ...
William Blair started coverage on shares of Structure Therapeutics (NASDAQ:GPCR – Free Report) in a research note published on Friday, Marketbeat Ratings reports. The brokerage issued an outperform ...